Elam-EvansLDYankeyDSingletonJA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13—17 years—United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1109-1116. doi:10.15585/mmwr.mm6933a1.
2.
ClaryKCortrightLTuminDBuckmanCEldridgeD.Primary care use and assessment of adolescents’ sexual health during hospitalization. Hosp Pediatr. 2020;10(11):963-968. doi:10.1542/hpeds.2020-0050.
3.
KongWYBustamanteGPallottoIK, et al. Disparities in healthcare providers’ recommendation of HPV vaccination for U.S. adolescents: a systematic review. Cancer Epidemiol Biomarkers Prev. 2021;30(11):1981-1992. doi:10.1158/1055-9965.EPI-21-0733.
4.
DorellCYankeyDJeyarajahJ, et al. Delay and refusal of human papillomavirus vaccine for girls, national immunization survey-teen, 2010. Clin Pediatr (Phila). 2014;53(3):261-269. doi:10.1177/0009922813520070.
5.
Sara TestFCaskeyRRankinKM. The relationship between receiving care within a medical home and HPV vaccine receipt for adolescent girls: results of the 2007 National Survey of Children’s Health. Matern Child Health J. 2013;17(2):274-281. doi:10.1007/s10995-012-0975-1.
6.
SeipelMM.The impact of medical home on selected children’s health outcome. Soc Work Health Care. 2011;50(5):347-359. doi:10.1080/00981389.2011.567129.
7.
DePBudhwaniH.Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health. 2017;144:86-91. doi:10.1016/j.puhe.2016.11.005.
8.
DoescherMPSaverBGFiscellaKFranksP.Preventive care. J Gen Intern Med. 2004;19(6):632-637. doi:10.1111/j.1525-1497.2004.21150.x.
9.
McReaAMooreBMorrisH, et al. Human papillomavirus vaccine series follow-through: comparison of four clinics in an academic medical center [published online ahead of print September 1, 2020]. Int J Adolesc Med Health. doi:10.1515/ijamh-2020-0145.
10.
SzilagyiPGAlbertinCSGurfinkelD, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020;38(38):6027-6037. doi:10.1016/j.vaccine.2020.06.074.
11.
CataldiJRO’LearySTMarkowitzLE, et al. Changes in strength of recommendation and perceived barriers to human papillomavirus vaccination: longitudinal analysis of primary care physicians, 2008-2018. J Pediatr. 2021;234:149-157.e3. doi:10.1016/j.jpeds.2021.03.002.
12.
BuckmanCLiuICCortrightLTuminDSyedS.The influence of local political trends on childhood vaccine completion in North Carolina. Soc Sci Med. 2020;260:113187. doi:10.1016/j.socscimed.2020.113187.
CaldwellACMaddenCAThompsonDM, et al. The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines. Hum Vaccin Immunother. 2021;17(4):1059-1067. doi:10.1080/21645515.2020.1817713.
15.
DempseyAFPyrznawoskiJLockhartS, et al. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016.
16.
ChenSTHuybrechtsKFBatemanBTHernández-DíazS.Trends in human papillomavirus vaccination in commercially insured children in the United States. Pediatrics. 2020;146(4):e20193557. doi:10.1542/peds.2019-3557.
